{"id":"W2061415759","doi":"10.1093/annonc/mdt459.53","title":"Phase III Study of Crizotinib vs. Chemotherapy in Advanced ALK+ NSCLC: Patient-Reported Symptoms and Quality of Life","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Crizotinib; Docetaxel; Internal medicine; Lung cancer; Quality of life (healthcare); Pemetrexed; Chemotherapy; ALK inhibitor; Phases of clinical research; Randomization; Performance status; Oncology; non-small cell lung cancer (NSCLC); Clinical trial; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001313197,0.001537763,0.003628846,0.0003702065,0.0004610594,0.001075224,0.001151782,0.00115733,0.003385266],"category_scores_gemma":[0.00107802,0.0004979311,0.001825376,0.0005613177,0.0009076388,0.0007745657,0.0003724106,0.003352022,0.0007939152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00200499,"about_ca_system_score_gemma":0.001869329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005008212,"about_ca_topic_score_gemma":0.01103099,"domain_scores_codex":[0.9994805,0.0002501332,0.00002233232,0.00009477411,0.00004740069,0.000104901],"domain_scores_gemma":[0.9990375,0.0001943323,0.0002189615,0.00007247006,0.00005440008,0.0004222415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9561602,0.009727743,0.002623241,0.0002584675,0.001255369,0.0000506647,0.0000595989,0.001225127,0.006283323,0.00006856319,0.001002378,0.0212853],"study_design_scores_gemma":[0.7823915,0.197129,0.01557709,0.0000245673,0.001094378,0.0001078767,0.0000650584,0.001353832,0.001093486,0.00016114,0.0009728984,0.00002920802],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939392,0.002319563,0.0002021503,0.0004075278,0.0001263778,0.0007205287,0.001120508,0.00004916349,0.001114958],"genre_scores_gemma":[0.99245,0.001691621,0.0006545567,0.0005353189,0.0001691479,0.000990035,0.001730216,0.00002731752,0.001751855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005008212,"threshold_uncertainty_score":0.01454735,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0706192058174058,"score_gpt":0.4626895640754646,"score_spread":0.3920703582580588,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}